CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
John Hunter Hospital
Newcastle, AustraliaPublications in collaboration with researchers from John Hunter Hospital (19)
2022
2021
-
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Neurology, Vol. 96, Núm. 24, pp. E2989-E3002
2019
-
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Multiple Sclerosis and Related Disorders, Vol. 28, pp. 235-243
2017
-
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice
Multiple Sclerosis, Vol. 23, Núm. 10, pp. 1346-1357
2016
-
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
Multiple Sclerosis, Vol. 22, Núm. 4, pp. 520-532
2015
-
BREMSO: A simple score to predict early the natural course of multiple sclerosis
European Journal of Neurology, Vol. 22, Núm. 6, pp. 981-989
-
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 9, pp. 1159-1171
-
Comparative efficacy of switching to natalizumab in active multiple sclerosis
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 4, pp. 373-387
-
Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS
PLoS ONE, Vol. 10, Núm. 6
-
Predictors of disability worsening in clinically isolated syndrome
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 5, pp. 479-491
2014
-
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
Multiple Sclerosis Journal, Vol. 20, Núm. 6, pp. 739-746
-
Risk of relapse phenotype recurrence in multiple sclerosis
Multiple Sclerosis Journal, Vol. 20, Núm. 11, pp. 1511-1522
-
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent
Annals of Neurology, Vol. 76, Núm. 6, pp. 880-890
2013
-
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
PLoS ONE, Vol. 8, Núm. 5
-
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
Brain, Vol. 136, Núm. 12, pp. 3609-3617
2012
-
Country, sex, edss change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome
PLoS ONE, Vol. 7, Núm. 6
-
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
PLoS ONE, Vol. 7, Núm. 10
-
Increasing age at disability milestones among MS patients in the MSBase Registry
Journal of the Neurological Sciences, Vol. 318, Núm. 1-2, pp. 94-99
-
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: Results from the MSBase Registry
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 83, Núm. 3, pp. 305-310